Fluconazole Prices in China
- China: 171770 USD/MT
In June 2023, the price of fluconazole in China reached 171,770 USD per metric ton for Q2 2023. The latest report by IMARC Group, titled "Fluconazole Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data" delivers a comprehensive analysis of Fluconazole prices on a global and regional scale, highlighting the pivotal factors contributing to price changes. This detailed examination includes spot price evaluations at key ports and an analysis of pricing structures, such as Ex Works, FOB, and CIF, across North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa.
Fluconazole Prices December 2023:
- China: 171770 USD/MT
- Germany: 172663 USD/MT
Report Offering:
- Monthly Updates: Annual Subscription
- Quarterly Updates: Annual Subscription
- Biannually Updates: Annual Subscription
The study delves into the factors affecting Fluconazole price variations, including alterations in the cost of raw materials, the balance of supply and demand, geopolitical influences, and sector-specific developments.
The report also incorporates the most recent updates from the market, equipping stakeholders with the latest information on market fluctuations, regulatory modifications, and technological progress. It serves as an exhaustive resource for stakeholders, enhancing strategic planning and forecast capabilities.
Request For a Sample Copy of the Report: https://www.imarcgroup.com/fluconazole-pricing-report/requestsample
Fluconazole Price Trend- Q4 2023
Fluconazole is an antifungal medication that belongs to the triazole class of drugs. It is commonly used to treat a variety of fungal infections, including candidiasis, cryptococcal meningitis, and other infections caused by susceptible strains of Candida and Cryptococcus species. Fluconazole works by inhibiting the fungal enzyme lanosterol 14-α-demethylase, which is crucial for the synthesis of ergosterol, a key component of fungal cell membranes. This disruption in ergosterol production compromises the integrity of the fungal cell membrane, leading to cell death. Fluconazole is available in several forms, including oral tablets, oral suspension, and intravenous (IV) formulations, providing flexibility in administration depending on the severity and location of the infection. It is well-absorbed when taken orally and has good tissue penetration, making it effective for both systemic and localized infections. It is often preferred for its relatively low side effect profile and its ability to be used in both immunocompromised and immunocompetent patients.
Fluconazole Market Analysis
The global fluconazole market size reached US$ 273 Million in 2023. By 2032, IMARC Group expects the market to reach US$ 365.7 Million, at a projected CAGR of 3.30% during 2023-2032. The global fluconazole market is experiencing robust growth driven by the increasing prevalence of fungal infections worldwide as more people require effective antifungal treatments like fluconazole. Concurrently, immunocompromised individuals, such as those with human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS), cancer patients, and organ transplant recipients, are particularly vulnerable to fungal infections, which is further strengthening the demand for fluconazole. This influenced fluconazole prices in North America, especially due to increasing demand from end-user sectors and logistical challenges caused by zero COVID policies. Similarly, Europe and Asia Pacific followed a similar pattern of price fluctuations due to heightened end-user demand and logistical issues. Additionally, the rise in chronic diseases and conditions that weaken the immune system further exacerbates this need, thereby impelling the market growth. Moreover, the aging global population, which is more susceptible to infections due to a natural decline in immune function, is contributing to the market expansion. Besides this, advancements in diagnostic technologies have led to earlier and more accurate detection of fungal infections, enabling timely treatment is providing an impetus to the market growth. Furthermore, the drug’s broad-spectrum activity and effectiveness against a wide range of fungal pathogens make it a preferred choice among healthcare providers, aiding in market expansion.
Browse Full Report: https://www.imarcgroup.com/fluconazole-pricing-report
Key Points Covered in the Fluconazole Pricing Report:
The report delivers the following key findings, alongside a comprehensive breakdown of prices by region:
- Fluconazole Prices
- Fluconazole Price Trend
- Fluconazole Demand & Supply
- Fluconazole Market Analysis
- Demand Supply Analysis by Type
- Demand Supply Analysis by Application
- Demand Supply Analysis of Raw Materials
- Fluconazole Price Analysis
- Fluconazole Industry Drivers, Restraints, and Opportunities
- Fluconazole News and Recent developments
- Global Event Analysis
- List of Key Players
Regional Price Analysis:
- Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand
- Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece
- North America: United States and Canada
- Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru
- Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco
Browse More Pricing Reports by IMARC Group:
Note: The current country list is selective, detailed insights into additional countries can be obtained for clients upon request.
About Us:
IMARC is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact us:
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
